Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133621) titled 'Clinical efficacy study on personalized corneal stromal ablation guided by topographic map combined with rapid corneal collagen cross-linking in the treatment of keratoconus' on Sept. 29.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Xi'an NO.1 Hospital

Condition: Keratoconus

Intervention: CXL (corneal collagen cross-linking):N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: CXL (corneal collagen cross-linking):15;T-CAT (topography-guided customized ablation with corneal collagen cross-linking):15;

Countrie...